Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial
Authors
Ahmed Dahiru Balami (ORCID: https://orcid.org/0000-0001-7370-4955)
Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial
Ahmed Dahiru Balami, Saloum Jallow, Bakary Sonko, Björn Sjöstrand et al.
Journal
The Lancet Infectious Diseases
Topics
Escherichia coli research studies
article
Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial
Ahmed Dahiru Balami, Saloum Jallow, Bakary Sonko, Björn Sjöstrand, Agneta Lissmats, Nils Carlin, Joanna Kaim, Olubunmi A Olubiyi, Thomas F Wierzba, Umberto D'Alessandro, Emmanuel U Richard, Emmanuel C Okoh, M Jahangir Hossain, Fatou Secka, Jacinta Obiaduo, Paticia Ezedimbu-Michael, Ann-Mari Svennerholm, Mama Drammeh, Mbemba Drammeh, Lady C Sanyang, Ousman Secka, Raifu Taiwo
article en
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Infectious Diseases
Institutions
MRC Unit the Gambia (GM), Wake Forest University (US), University of Gothenburg (SE)